
Taro Pharmaceutical Industries has received approval for its ANDA of meloxicam tablets 7.5 mg and 15 mg for the relief of the signs and symptoms of osteo-arthritis and rheumatoid arthritis. This Taro product is bioequivalent to Boeh-ringer Ingelheim’s Mobic Tablets.

